Intervet International B.V.

Random entry RSS

Posted in:
News

PTAB Exercises its § 325(d) Discretion to Deny IPR of Piglet Vaccine Patent
By Benjamin R. Holt November 5, 2018 Comments are off
The August 2018 Update to the PTAB Trial Practice Guide added guidance regarding the Patent Trial and Appeal Board’s (“the Board”)...

Read more

Tagged with: Boehringer Ingelheim, Intervet International B.V., IPR, Merial, News, PTAB

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top